Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma
Clinical trial NCT06737146 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06737146
- Sponsor
- Suzhou Maximum Bio-tech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.